Bone Marrow Stem Cells Significantly Improve Cardiac Mortality Rate in Heart Disease Patients Read More » January 25, 2012
Medistem and Licensee ERCell Receive Russian Regulatory Approval for the RECOVER-ERC Trial Read More » January 24, 2012
Excerpts from Interview with Dr. Amit Patel, Director of Regenerative Medicine, University of Utah by Thomas Ichim, Ph.D, CEO of Medistem Inc Read More » January 12, 2012
Stem Cell Institute in Panama Collaborates on New Method of Treating Diabetes-Associated Heart Disease Read More » December 15, 2010